Research & Literature

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.

Castro M, Zangrilli J, Wechsler ME, et al.

The Lancet. Respiratory medicine 2015; (3(5)):355-66.

Supported self-management for asthma.

Pinnock H

Breathe (Sheffield, England) 2015; (11(2)):98-109 doi:10.1183/20734735.015614.

Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.

van Rijt L, von Richthofen H, van Ree R

Seminars in immunopathology 2016; (38(4)):483-96 doi:10.1007/s00281-016-0556-2.

Near fatal asthma: treatment and prevention.

D'Amato G, Vitale C, Lanza M, et al.

European annals of allergy and clinical immunology 2016; (48(4)):116-22.

Indoor allergen exposure and asthma outcomes.

Sheehan WJ, Phipatanakul W

Current opinion in pediatrics 2016; (28(6)):772-777 doi:10.1097/MOP.0000000000000421.

Asthma Exacerbations in a Tertiary Hospital: Clinical Features, Triggers, and Risk Factors for Hospitalization.

Pola-Bibian B, Dominguez-Ortega J, Vilà-Nadal G, et al.

Journal of investigational allergology & clinical immunology 2024; (27(4)):238-245 doi:10.18176/jiaci.0128.

Use of a low-literacy written action plan to improve parent understanding of pediatric asthma management: A randomized controlled study.

Yin HS, Gupta RS, Mendelsohn AL, et al.

The Journal of asthma : official journal of the Association for the Care of Asthma 2017; (54(9)):919-929 doi:10.1080/02770903.2016.1277542.

Medications and Recent Patents for Status Asthmaticus in Children.

Hon KLE, Leung AKC

Recent patents on inflammation & allergy drug discovery 2017; (11(1)):12-21 doi:10.2174/1872213X11666170130143524.

Airway Hyperresponsiveness in Asthma: Measurement and Clinical Relevance.

Nair P, Martin JG, Cockcroft DC, et al.

The journal of allergy and clinical immunology. In practice 2017; (5(3)):649-659.e2 doi:10.1016/j.jaip.2016.11.030.

Innate and adaptive type 2 immunity in lung allergic inflammation.

Kubo M

Immunological reviews 2017; (278(1)):162-172 doi:10.1111/imr.12557.

Magnesium sulfate infusion for acute asthma in the emergency department.

Irazuzta JE, Chiriboga N

Jornal de pediatria 2017; (93 Suppl 1()):19-25 doi:10.1016/j.jped.2017.06.002.

Relationship between total serum immunoglobulin E levels, fractional exhaled breath nitric oxide levels and absolute blood eosinophil counts in atopic and non-atopic asthma: a controlled comparative study.

Shrestha SK, Drews A, Sharma L, et al.

Journal of breath research 2018; (12(2)):026009 doi:10.1088/1752-7163/aa95da.

Advances and Evolving Concepts in Allergic Asthma.

Tung HY, Li E, Landers C, et al.

Seminars in respiratory and critical care medicine 2018; (39(1)):64-81 doi:10.1055/s-0037-1607981.

Allergen-Specific Immunotherapy in the Treatment of Pediatric Asthma: A Systematic Review.

Rice JL, Diette GB, Suarez-Cuervo C, et al.

Pediatrics 2018; (141(5)) doi:10.1542/peds.2017-3833.

Guideline on management of the acute asthma attack in children by Italian Society of Pediatrics.

Indinnimeo L, Chiappini E, Miraglia Del Giudice M,

Italian journal of pediatrics 2018; (44(1)):46 doi:10.1186/s13052-018-0481-1.

Medication Regimens for Managing Acute Asthma.

Maselli DJ, Peters JI

Respiratory care 2018; (63(6)):783-796 doi:10.4187/respcare.05953.

Effect of Nasal Obstructive Disorders on Sinonasal Symptoms in Children with Different Levels of Bronchial Asthma Control.

Eliseeva TI, Krasilnikova SV, Geppe NA, et al.

Canadian respiratory journal 2018; (2018()):4835823 doi:10.1155/2018/4835823.

Immunological Processes Driving IgE Sensitisation and Disease Development in Males and Females.

Leffler J, Stumbles PA, Strickland DH

International journal of molecular sciences 2018; (19(6)) doi:10.3390/ijms19061554.

BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007).

Scadding GK, Kariyawasam HH, Scadding G, et al.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2017; (47(7)):856-889 doi:10.1111/cea.12953.

ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing.

Hallstrand TS, Leuppi JD, Joos G, et al.

The European respiratory journal 2018; (52(5)) doi:10.1183/13993003.01033-2018.

Epithelial cell-derived cytokines: more than just signaling the alarm.

Roan F, Obata-Ninomiya K, Ziegler SF

The Journal of clinical investigation 2019; (129(4)):1441-1451.

EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma.

Agache I, Lau S, Akdis CA, et al.

Allergy 2019; (74(5)):855-873 doi:10.1111/all.13749.

Viruses and non-allergen environmental triggers in asthma.

Chau-Etchepare F, Hoerger JL, Kuhn BT, et al.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2019; (67(7)):1029-1041 doi:10.1136/jim-2019-001000.

Long-term evaluation of response to omalizumab therapy in real life by a novel multimodular approach: The Real-life Effectiveness of Omalizumab Therapy (REALITY) study.

Singh H, Peters JI, Kaur Y, et al.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2019; (123(5)):476-482.e1 doi:10.1016/j.anai.2019.07.026.

Anti-alarmin approaches entering clinical trials.

Gauvreau GM, White L, Davis BE

Current opinion in pulmonary medicine 2020; (26(1)):69-76 doi:10.1097/MCP.0000000000000615.

[Chinese guidelines for the diagnosis and treatment of allergic asthma (2019, the first edition)].

,

Zhonghua nei ke za zhi 2019; (58(9)):636-655 doi:10.3760/cma.j.issn.0578-1426.2019.09.004.

Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline.

Holguin F, Cardet JC, Chung KF, et al.

The European respiratory journal 2020; (55(1)) doi:10.1183/13993003.00588-2019.

Acute severe asthma (status asthmaticus).

Agnihotri NT, Saltoun C

Allergy and asthma proceedings 2019; (40(6)):406-409 doi:10.2500/aap.2019.40.4258.

Targeting treatable traits in severe asthma: a randomised controlled trial.

McDonald VM, Clark VL, Cordova-Rivera L, et al.

The European respiratory journal 2020; (55(3)) doi:10.1183/13993003.01509-2019.

Age-specific incidence of allergic and non-allergic asthma.

Pakkasela J, Ilmarinen P, Honkamäki J, et al.

BMC pulmonary medicine 2020; (20(1)):9 doi:10.1186/s12890-019-1040-2.

A comparison of tiotropium, long-acting β2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma.

Vogelberg C, Goldstein S, Graham L, et al.

Respiratory research 2020; (21(1)):19 doi:10.1186/s12931-020-1282-9.

The role of atopy in asthma development and persistence.

Di Cicco M, D'Elios S, Peroni DG, Comberiati P

Current opinion in allergy and clinical immunology 2020; (20(2)):131-137 doi:10.1097/ACI.0000000000000627.

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.

Agache I, Beltran J, Akdis C, et al.

Allergy 2020; (75(5)):1023-1042 doi:10.1111/all.14221.

Allergic Endotypes and Phenotypes of Asthma.

Akar-Ghibril N, Casale T, Custovic A, Phipatanakul W

The journal of allergy and clinical immunology. In practice 2020; (8(2)):429-440 doi:10.1016/j.jaip.2019.11.008.

The impact of dysfunctional breathing on the level of asthma control in difficult asthma.

Sedeh FB, Von Bülow A, Backer V, et al.

Respiratory medicine 2020; (163()):105894 doi:10.1016/j.rmed.2020.105894.

Multinational cohort study of mortality in patients with asthma and severe asthma.

Engelkes M, de Ridder MA, Svensson E, et al.

Respiratory medicine 2020; (165()):105919 doi:10.1016/j.rmed.2020.105919.

Effectiveness of the Air Purification Strategies for the Treatment of Allergic Asthma: A Meta-Analysis.

van Boven FE, de Jong NW, Braunstahl GJ, et al.

International archives of allergy and immunology 2020; (181(5)):395-402 doi:10.1159/000506284.

Evaluation and management of the critically ill adult asthmatic in the emergency department setting.

Long B, Lentz S, Koyfman A, Gottlieb M

The American journal of emergency medicine 2021; (44()):441-451 doi:10.1016/j.ajem.2020.03.029.

Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma.

Frix AN, Schleich F, Paulus V, et al.

Biochemical pharmacology 2020; (179()):113944 doi:10.1016/j.bcp.2020.113944.

Performance Characteristics of Spirometry With Negative Bronchodilator Response and Methacholine Challenge Testing and Implications for Asthma Diagnosis.

Selvanathan J, Aaron SD, Sykes JR, et al.

Chest 2020; (158(2)):479-490 doi:10.1016/j.chest.2020.03.052.

Type 2 immunity in the skin and lungs.

Akdis CA, Arkwright PD, Brüggen MC, et al.

Allergy 2020; (75(7)):1582-1605 doi:10.1111/all.14318.

Pragmatic Clinical Perspective on Biologics for Severe Refractory Type 2 Asthma.

Chan R, RuiWen Kuo C, Lipworth B

The journal of allergy and clinical immunology. In practice 2020; (8(10)):3363-3370 doi:10.1016/j.jaip.2020.06.048.

Advances in allergen immunotherapy for asthma.

Agache I, Laculiceanu A, Cojanu C, et al.

Current opinion in allergy and clinical immunology 2020; (20(6)):602-608 doi:10.1097/ACI.0000000000000686.

Hypercapnia: An Aggravating Factor in Asthma.

Shigemura M, Homma T, Sznajder JI

Journal of clinical medicine 2020; (9(10)) doi:10.3390/jcm9103207.

The Myth of Mild: Severe Exacerbations in Mild Asthma: An Underappreciated, but Preventable Problem.

Kaplan A

Advances in therapy 2021; (38(3)):1369-1381 doi:10.1007/s12325-020-01598-2.

Inhaled long-acting muscarinic antagonists in asthma - A narrative review.

Papi A, Fabbri LM, Kerstjens HAM, et al.

European journal of internal medicine 2021; (85()):14-22 doi:10.1016/j.ejim.2021.01.027.

[Treatment of GERD in asthma].

Launois C, Mulette P, Ancel J, et al.

Revue des maladies respiratoires 2021; (38(7)):733-742 doi:10.1016/j.rmr.2021.04.013.

Dexmedetomidine as an adjunctive treatment for acute asthma.

Motamed H, Forouzan A, Moezzi M, Alizadeh H

Clinical and experimental emergency medicine 2021; (8(2)):89-93 doi:10.15441/ceem.20.038.

The ALPACA study: (In)Appropriate LAMA prescribing in asthma: A cohort analysis.

Baan EJ, Hoeve CE, De Ridder M, et al.

Pulmonary pharmacology & therapeutics 2021; (71()):102074 doi:10.1016/j.pupt.2021.102074.

A Practical Guide to Implementing SMART in Asthma Management.

Reddel HK, Bateman ED, Schatz M, et al.

The journal of allergy and clinical immunology. In practice 2022; (10(1S)):S31-S38 doi:10.1016/j.jaip.2021.10.011.

Different effects of smoking on atopic and non-atopic adult-onset asthma.

Lajunen TK, Jaakkola JJK, Jaakkola MS

Clinical and translational allergy 2021; (11(8)):e12072 doi:10.1002/clt2.12072.

Managing an acute asthma exacerbation in children.

Trottier ED, Chan K, Allain D, Chauvin-Kimoff L

Paediatrics & child health 2021; (26(7)):438-439 doi:10.1093/pch/pxab058.

Clinical value of bronchodilator response for diagnosing asthma in steroid-naïve adults.

Tuomisto LE, Ilmarinen P, Lehtimäki L, et al.

ERJ open research 2021; (7(4)) doi:10.1183/23120541.00293-2021.

Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.

Corren J, Pham TH, Garcia Gil E, et al.

Allergy 2022; (77(6)):1786-1796 doi:10.1111/all.15197.

Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma.

Porsbjerg CM, Menzies-Gow AN, Tran TN, et al.

The journal of allergy and clinical immunology. In practice 2022; (10(5)):1202-1216.e23 doi:10.1016/j.jaip.2021.12.027.

European Respiratory Society guidelines for the diagnosis of asthma in adults.

Louis R, Satia I, Ojanguren I, et al.

The European respiratory journal 2022; (60(3)) doi:10.1183/13993003.01585-2021.

Efficacy and Safety of House Dust Mite Sublingual Immunotherapy Tablet in Allergic Asthma: A Systematic Review of Randomized Controlled Trials.

Wongsa C, Phinyo P, Sompornrattanaphan M, et al.

The journal of allergy and clinical immunology. In practice 2022; (10(5)):1342-1355.e24 doi:10.1016/j.jaip.2022.01.046.

Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.

Beasley R, Harrison T, Peterson S, et al.

JAMA network open 2022; (5(3)):e220615 doi:10.1001/jamanetworkopen.2022.0615.

Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.

Reddel HK, Bacharier LB, Bateman ED, et al.

Archivos de bronconeumologia 2022; (58(1)):35-51 doi:10.1016/j.arbres.2021.10.003.

Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It.

Vertadier N, Trzepizur W, Faure S

Sports (Basel, Switzerland) 2022; (10(3)) doi:10.3390/sports10030036.

Emerging Insights into the Impact of Air Pollution on Immune-Mediated Asthma Pathogenesis.

Tuazon JA, Kilburg-Basnyat B, Oldfield LM, et al.

Current allergy and asthma reports 2022; (22(7)):77-92 doi:10.1007/s11882-022-01034-1.

Implementation of a Children's Safe Asthma Discharge Care Pathway Reduces the Risk of Future Asthma Attacks in Children-A Retrospective Quality Improvement Report.

Kennedy L, Gallagher G, Maxwell B, et al.

Frontiers in pediatrics 2022; (10()):865476 doi:10.3389/fped.2022.865476.

Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparison.

Menzies-Gow A, Steenkamp J, Singh S, et al.

Journal of medical economics 2022; (25(1)):679-690 doi:10.1080/13696998.2022.2074195.

Characteristics, phenotypes, mechanisms and management of severe asthma.

Chung KF, Dixey P, Abubakar-Waziri H, et al.

Chinese medical journal 2022; (135(10)):1141-1155 doi:10.1097/CM9.0000000000001990.

Allergic Asthma in the Era of Personalized Medicine.

Papapostolou N, Makris M

Journal of personalized medicine 2022; (12(7)) doi:10.3390/jpm12071162.

The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma.

Matsuyama T, Matsuyama H, Dotake Y, et al.

Frontiers in immunology 2022; (13()):930862 doi:10.3389/fimmu.2022.930862.

Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype.

Rabe KF, FitzGerald JM, Bateman ED, et al.

The journal of allergy and clinical immunology. In practice 2022; (10(11)):2916-2924.e4 doi:10.1016/j.jaip.2022.06.036.

Clinical implications of asthma endotypes and phenotypes.

Taunk ST, Cardet JC, Ledford DK

Allergy and asthma proceedings 2022; (43(5)):375-382 doi:10.2500/aap.2022.43.220047.

An overview on the RSV-mediated mechanisms in the onset of non-allergic asthma.

Manti S, Piedimonte G

Frontiers in pediatrics 2022; (10()):998296 doi:10.3389/fped.2022.998296.

Inhaler Non-Adherence, Associated Factors and Asthma Control among Asthma Patients in a Tertiary Level Hospital in Tanzania.

Shayo GA, Omary A, Mugusi F

The East African health research journal 2022; (6(1)):78-85 doi:10.24248/eahrj.v6i1.682.

The Impact of Tezepelumab in Uncontrolled Severe Asthma: A Systematic Review of Randomized Controlled Trials.

Roy P, Rafa ZI, Haque SN, et al.

Cureus 2022; (14(12)):e32156 doi:10.7759/cureus.32156.

Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials.

Corren J, Menzies-Gow A, Chupp G, et al.

American journal of respiratory and critical care medicine 2023; (208(1)):13-24 doi:10.1164/rccm.202210-2005OC.

Inhaled Corticosteroids Rarely Prescribed at Emergency Department Discharge Despite Low Rates of Follow-Up Care.

Kligler SK, Vargas-Torres C, Abbott EE, Lin MP

The Journal of emergency medicine 2023; (64(5)):555-563 doi:10.1016/j.jemermed.2023.02.013.

T-helper cells and their cytokines in pathogenesis and treatment of asthma.

Ji T, Li H

Frontiers in immunology 2023; (14()):1149203 doi:10.3389/fimmu.2023.1149203.

Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review.

Zheng C, Xu H, Huang S, Chen Z

Frontiers in pediatrics 2023; (11()):1137478 doi:10.3389/fped.2023.1137478.

How can we improve our use of allergen immunotherapy as a treatment option for asthma and severe asthma?

Larenas-Linnemann D, Morfin Maciel BM

Expert review of respiratory medicine 2023; (17(8)):717-725 doi:10.1080/17476348.2023.2251403.

A cross sectional observational study on uncontrolled bronchial asthma and inhaler technique among out patients in a tertiary care centre in Western Maharashtra.

Shrinath V, Thatikonda A, Pandey I, et al.

Lung India : official organ of Indian Chest Society 2023; (40(5)):440-444 doi:10.4103/lungindia.lungindia_559_22.

The treatable traits approach to adults with obstructive airways disease in primary and secondary care.

Thomas M, Beasley R

Respirology (Carlton, Vic.) 2023; (28(12)):1101-1116 doi:10.1111/resp.14610.

Adherence to National Asthma Guidelines in the Acute Care Setting: A Retrospective Cohort Study.

Hussain M, Hassan T, Hussain G, et al.

Cureus 2023; (15(11)):e48725 doi:10.7759/cureus.48725.

Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics.

Bourdin A, Brusselle G, Couillard S, et al.

The journal of allergy and clinical immunology. In practice 2024; (12(4)):809-823 doi:10.1016/j.jaip.2024.01.023.

Airway hyperresponsiveness in asthma: The role of the epithelium.

Bradding P, Porsbjerg C, Côté A, et al.

The Journal of allergy and clinical immunology 2024; (153(5)):1181-1193 doi:10.1016/j.jaci.2024.02.011.

What is the Best Way to Diagnose Possible Asthma Patients with Negative Bronchodilator Reversibility Tests?

Başa Akdoğan B, Koca Kalkan I, Köycü Buhari G, et al.

Journal of asthma and allergy 2024; (17()):113-122 doi:10.2147/JAA.S437756.

Are nighttime respiratory symptoms assessed by asthma control test affected by comorbidities?

Benfante A, Tomasello A, Caponetto C, et al.

The Journal of asthma : official journal of the Association for the Care of Asthma 2024; (61(9)):1083-1088 doi:10.1080/02770903.2024.2327036.

Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database.

Cutroneo PM, Arzenton E, Furci F, et al.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2024; (38(3)):425-448 doi:10.1007/s40259-024-00653-6.

The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma.

Nakagome K, Nagata M

Biomolecules 2024; (14(5)) doi:10.3390/biom14050546.

Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement.

Laitano R, Calzetta L, Matino M, et al.

Expert opinion on pharmacotherapy 2024; (25(8)):1071-1081 doi:10.1080/14656566.2024.2366991.

Obesity and Asthma: Implementing a Treatable Trait Care Model.

Mendes FC, Garcia-Larsen V, Moreira A

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2024; (54(11)):881-894 doi:10.1111/cea.14520.

House dust mite allergen avoidance strategies for the treatment of allergic asthma: A hypothesis-generating meta-analysis.

van Boven FE, Braunstahl GJ, Arends LR, et al.

The World Allergy Organization journal 2024; (17(6)):100919 doi:10.1016/j.waojou.2024.100919.

Ketamine as an Adjunct Therapy in Acute Severe Asthma: An In-Depth Review of Efficacy and Clinical Implications.

Epperson J, Athar ZM, Arshad M, Chen EY

Cureus 2024; (16(6)):e62483 doi:10.7759/cureus.62483.

Impact of comorbidities on EQ-5D quality-of-life index in severe asthma.

Pfeffer PE, Brown T, Chaudhuri R, et al.

The journal of allergy and clinical immunology. Global 2024; (3(3)):100286 doi:10.1016/j.jacig.2024.100286.

Coke oven emissions exacerbate allergic asthma by promoting ferroptosis in airway epithelial cells.

Chen X, Chen H, Zhang P, et al.

Journal of hazardous materials 2024; (478()):135542 doi:10.1016/j.jhazmat.2024.135542.

Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways.

Eggel A, Pennington LF, Jardetzky TS

Immunological reviews 2024; (328(1)):387-411 doi:10.1111/imr.13380.

Asthma diagnosis: a comparison of established diagnostic guidelines in adults with respiratory symptoms.

Simpson AJ, Drake S, Healy L, et al.

EClinicalMedicine 2024; (76()):102813 doi:10.1016/j.eclinm.2024.102813.

How type-2 dendritic cells induce Th2 differentiation: Instruction, repression, or fostering T cell-T cell communication?

Ronchese F, Webb GR, Ochiai S, et al.

Allergy 2025; (80(2)):395-407 doi:10.1111/all.16337.

Update on Asthma Management Guidelines.

Dubin S, Patak P, Jung D

Missouri medicine 2024; (121(5)):364-367.

Lifetime asthma incidence is related to age at onset and allergies in western Sweden.

Abohalaka R, Ercan S, Lehtimäki L, et al.

Clinical and translational allergy 2024; (14(12)):e70015 doi:10.1002/clt2.70015.

Role of the Respiratory Therapist in Asthma Education.

Willis LD

Respiratory care 2025; (70(6)):709-720 doi:10.1089/respcare.12546.

Targeting IL-13 and IL-4 in Asthma: Therapeutic Implications on Airway Remodeling in Severe Asthma.

Sahnoon L, Bajbouj K, Mahboub B, et al.

Clinical reviews in allergy & immunology 2025; (68(1)):44 doi:10.1007/s12016-025-09045-2.

Biologic Therapies for Severe Asthma: Current Insights and Future Directions.

Faria N, Costa MI, Fernandes AL, et al.

Journal of clinical medicine 2025; (14(9)) doi:10.3390/jcm14093153.

High Prevalence of Uncontrolled Asthma and Its Association With Obesity and GERD-Related Symptoms in Syria: A Multicenter Cross-Sectional Study.

Bakdounes D, Dughly R, Almasri IA, et al.

Health science reports 2025; (8(5)):e70828 doi:10.1002/hsr2.70828.

Nocturnal oximetry profile in hospitalized children with asthma exacerbation upon hospital discharge.

Panagiotou P, Chantzaras AP, Sergentanis TN, et al.

Sleep medicine 2025; (134()):106668 doi:10.1016/j.sleep.2025.106668.

Safety and Efficacy of Dupilumab, Omalizumab, and Mepolizumab in Moderate-to-Severe Asthma: A Systematic Review.

O Omar ZT, Owodeha-Ashaka M, Okobi OE, et al.

Cureus 2025; (17(7)):e88236 doi:10.7759/cureus.88236.

4-Week Maintenance ICS-Formoterol versus ICS in Adults Newly Diagnosed Mild Asthma: Effects on Symptoms, Lung Function, and Inflammation.

Zhou Y, Zhang X, Xu Z, et al.

Current allergy and asthma reports 2025; (25(1)):40 doi:10.1007/s11882-025-01217-6.

Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trial.

Nihashi F, Furuhashi K, Niwa M, et al.

Respiratory medicine and research 2025; (88()):101191 doi:10.1016/j.resmer.2025.101191.

Successful Non-Invasive Management of Near-Fatal Asthma with Severe Hypercapnic Respiratory Failure: A Case Report.

Adan HAA, Dirie AMH

International medical case reports journal 2025; (18()):1513-1517 doi:10.2147/IMCRJ.S562837.

A review of the safety of antibody therapy in severe eosinophilic asthma.

Matera MG, De Novellis V, Rogliani P, Cazzola M

Expert review of respiratory medicine 2026; (20(6)):673-692 doi:10.1080/17476348.2025.2607151.

Recognising and managing acute asthma attacks in adults in the emergency department.

Colton S

Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association 2026; (34(4)):13-19 doi:10.7748/en.2026.e2250.

Using biomarkers and independent predictors of therapy response to optimize treatment of uncontrolled severe asthma in the biologic era.

Yasui H

Frontiers in allergy 2025; (6()):1719820 doi:10.3389/falgy.2025.1719820.

Beyond biomarkers: the role of clinical factors associated with biologic therapy response in severe asthma.

Lopez-Rodríguez R, Cañas JA, Mahíllo-Fernández I, Rial MJ

Annals of medicine 2026; (58(1)):2627026 doi:10.1080/07853890.2026.2627026.

Beta2-agonist and anti-inflammatory combination therapy for asthma rescue: a paradigm shift in asthma care.

Skolnik N, Stieritz J, Akers J, et al.

Frontiers in medicine 2026; (13()):1826737 doi:10.3389/fmed.2026.1826737.

Asthma diagnosis in adults and children: challenges, future directions, and a call to action.

Hassan W, Wang R, Mohammedalhadi A, et al.

The Lancet. Respiratory medicine 2026; doi:10.1016/S2213-2600(26)00143-8.

Biomarkers in pediatric asthma: clinical maturity, intended use, and future directions.

Fujisawa T, Iwai F

Allergology international : official journal of the Japanese Society of Allergology 2026; (75(4)):529-537 doi:10.1016/j.alit.2026.08.003.

Allergic Respiratory Diseases in the Climate Change Context: Aerobiological Tools and Projections as Preventive Actions for Pollen-Induced Allergies.

D'Ovidio MC, Ciardini V, Lancia A, et al.

Medical sciences (Basel, Switzerland) 2026; (14(4)) doi:10.3390/medsci14040466.

Acute Severe Asthma in the Intensive Care Unit: From Bronchodilators to Extracorporeal Membrane Oxygenation.

Abedi P, Chupp G, Wilson G, et al.

Journal of intensive care medicine 2026; 8850666261466238 doi:10.1177/08850666261466238.

Pathogenic group 2 innate lymphoid cells as drivers of lung fibrosis in severe asthma.

Matsuda M, Sannomiya Y, Kaminuma O, Nabe T

Frontiers in immunology 2026; (17()):1957593 doi:10.3389/fimmu.2026.1957593.